MedTrace Logo

Post-marketing Safety Surveillance of the Injection of DanShenDuoFenSuanYan A Real World Study

NCT01872520 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30180

Last updated 2015-10-27

No results posted yet for this study

Summary

Magnesium Lithospermate B, the main constituent of the Injection of DanShenDuoFenSuanYan (the Injection of Depsides Salts From Salvia Miltiorrhiza), is the active ingredient of Salvia Miltiorrhiza. This study record clinical use of The injection of DanShenDuoFenSuanYan in the real world, and observe the adverse drug reactions/ adverse drug events during treatment.

Conditions

  • Adverse Drug Reaction

Sponsors & Collaborators

  • Shanghai Greenvalley Pharmaceutical Co., Ltd.

    collaborator INDUSTRY

  • Peking University

    collaborator OTHER

  • Peking University Third Hospital

    lead OTHER

Principal Investigators

  • Suodi ZHAI, B.S. · Peking University Third Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01872520 on ClinicalTrials.gov